Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

A. Sonnenblick; A. Bailey; B. Uziely; M. Untch; I. Smith; L. Gianni; J. Baselga; C. Jackisch; D. Cameron; R. Bell; D. Zardavas; N. Al-Sakaff; R. Gelber; M. Dowsett; B. Leyland-Jones; M. Piccart; E. De azambuja

doi:10.1093/annonc/mdy270.213

Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

A. Sonnenblick, A. Bailey, B. Uziely, M. Untch, I. Smith, L. Gianni, J. Baselga, C. Jackisch, D. Cameron, R. Bell, D. Zardavas, N. Al-Sakaff, R. Gelber, M. Dowsett, B. Leyland-Jones, M. Piccart, E. De azambuja

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	viii70
Journal	Annals of Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy270.213
Publication status	Published - 1 Oct 2018

Access to Document

10.1093/annonc/mdy270.213Licence: Other

https://linkinghub.elsevier.com/retrieve/pii/S0923753419486419

Cite this

Sonnenblick, A., Bailey, A., Uziely, B., Untch, M., Smith, I., Gianni, L., Baselga, J., Jackisch, C., Cameron, D., Bell, R., Zardavas, D., Al-Sakaff, N., Gelber, R., Dowsett, M., Leyland-Jones, B., Piccart, M., & De azambuja, E. (2018). Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. Annals of Oncology, 29, viii70. https://doi.org/10.1093/annonc/mdy270.213

@article{f9203675fae5453ebff96061e1dac404,

title = "Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial",

author = "A. Sonnenblick and A. Bailey and B. Uziely and M. Untch and I. Smith and L. Gianni and J. Baselga and C. Jackisch and D. Cameron and R. Bell and D. Zardavas and N. Al-Sakaff and R. Gelber and M. Dowsett and B. Leyland-Jones and M. Piccart and {De azambuja}, E.",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy270.213",

language = "English",

volume = "29",

pages = "viii70",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

}

Sonnenblick, A, Bailey, A, Uziely, B, Untch, M, Smith, I, Gianni, L, Baselga, J, Jackisch, C, Cameron, D, Bell, R, Zardavas, D, Al-Sakaff, N, Gelber, R, Dowsett, M, Leyland-Jones, B, Piccart, M & De azambuja, E 2018, 'Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial', Annals of Oncology, vol. 29, pp. viii70. https://doi.org/10.1093/annonc/mdy270.213

TY - JOUR

T1 - Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

AU - Sonnenblick, A.

AU - Bailey, A.

AU - Uziely, B.

AU - Untch, M.

AU - Smith, I.

AU - Gianni, L.

AU - Baselga, J.

AU - Jackisch, C.

AU - Cameron, D.

AU - Bell, R.

AU - Zardavas, D.

AU - Al-Sakaff, N.

AU - Gelber, R.

AU - Dowsett, M.

AU - Leyland-Jones, B.

AU - Piccart, M.

AU - De azambuja, E.

PY - 2018/10/1

Y1 - 2018/10/1

U2 - 10.1093/annonc/mdy270.213

DO - 10.1093/annonc/mdy270.213

M3 - Article

SN - 0923-7534

VL - 29

SP - viii70

JO - Annals of Oncology

JF - Annals of Oncology

ER -